PMID- 34633654 OWN - NLM STAT- MEDLINE DCOM- 20220204 LR - 20220218 IS - 1749-0774 (Electronic) IS - 0914-7470 (Print) IS - 0914-7470 (Linking) VI - 35 IP - 1 DP - 2022 Jan TI - F-circEA1 regulates cell proliferation and apoptosis through ALK downstream signaling pathway in non-small cell lung cancer. PG - 260-270 LID - 10.1007/s13577-021-00628-7 [doi] AB - Studies have confirmed that circular RNA (circRNA) has a stable closed structure, which plays an important role in the progression of tumors. Cancers with positive fusion genes can produce associated fusion circRNA (F-cirRNA). However, there are no reports concerning a role for F-circRNA of the echinoderm microtubule associated-protein like 4-anaplastic lymphoma kinase variant 1 (EML4-ALK1) in non-small cell lung cancer (NSCLC). Our study confirmed the existence of fusion circEA1 (F-circEA1) in NCI-H3122 cells (carrying the EML4-ALK1 gene), F-circEA1 was expressed both in the cytoplasm and nucleus as determined by fluorescence in situ hybridization (FISH) and Sanger sequencing. CCK8 and transwell assays showed that F-circEA1 was beneficial to cell proliferation, metastasis, and invasion. Overexpression of F-circEA1 can also promote cell proliferation, migration and invasion in A549 and SPCA1 cells (non-small cell lung cancer cell line not carrying the EML4-ALK1 gene). Interference with F-circEA1, induced cell cycle arrest and promoted apoptosis as determined by flow cytometry, and increased drug sensitivity to crizotinib in H3122 cells. F-circEA1 directly affected the expression of parental gene EML4-ALK1. Further research found that F-circEA1 can affect the downstream signaling pathway of ALK. In vivo, the growth rate of xenogeneic tumors was reduced and the protein expression level of EML4-ALK1 was significantly decreased in transplanted tumors measured by immunohistochemistry (IHC) after interference with F-circEA1. In conclusion, F-circEA1 can be considered as a proto-oncogene that regulates cell proliferation and apoptosis by affecting the expression of the parental gene EML4-ALK1 and its ALK downstream signaling pathway in non-small cell lung cancer. CI - (c) 2021. The Author(s). FAU - Huo, Yinping AU - Huo Y AUID- ORCID: 0000-0001-6937-0964 AD - Department of Respiratory Medicine, Jinling Hospital, Nanjing Medical University, No 305, East Zhongshan Road, Xuanwu District, Nanjing, 210002, China. AD - Department of Respiratory Medicine, Pukou Branch Hospital of Jiangsu Province Hospital, No 166, Jiangpu Street, Pukou District, Nanjing, 211800, China. FAU - Lv, Tangfeng AU - Lv T AD - Department of Respiratory Medicine, Jinling Hospital, Nanjing Medical University, No 305, East Zhongshan Road, Xuanwu District, Nanjing, 210002, China. FAU - Ye, Mingxiang AU - Ye M AD - Department of Respiratory Medicine, Jinling Hospital, Nanjing Medical University, No 305, East Zhongshan Road, Xuanwu District, Nanjing, 210002, China. FAU - Zhu, Suhua AU - Zhu S AD - Department of Respiratory Medicine, Jinling Hospital, Nanjing Medical University, No 305, East Zhongshan Road, Xuanwu District, Nanjing, 210002, China. FAU - Liu, Jiaxin AU - Liu J AD - Department of Respiratory Medicine, Jinling Hospital, Nanjing Medical University, No 305, East Zhongshan Road, Xuanwu District, Nanjing, 210002, China. FAU - Liu, Hongbing AU - Liu H AD - Department of Respiratory Medicine, Jinling Hospital, Nanjing Medical University, No 305, East Zhongshan Road, Xuanwu District, Nanjing, 210002, China. netlhb@126.com. FAU - Song, Yong AU - Song Y AD - Department of Respiratory Medicine, Jinling Hospital, Nanjing Medical University, No 305, East Zhongshan Road, Xuanwu District, Nanjing, 210002, China. yong_song6310@yahoo.com. LA - eng GR - Grant Nos. 81572273/National Natural Science Foundation of China/ GR - No. QNRC2016911/Senior Talent Foundation of Jiangsu University/ GR - No. YKK16246/Nanjing Medical Science and Technology Development Project/ PT - Journal Article DEP - 20211011 PL - Japan TA - Hum Cell JT - Human cell JID - 8912329 RN - 0 (Cell Cycle Proteins) RN - 0 (Microtubule-Associated Proteins) RN - 0 (RNA, Circular) RN - EC 2.7.11.30 (ACVRL1 protein, human) RN - EC 2.7.11.30 (Activin Receptors, Type II) RN - EC 3.4.21.- (EML4 protein, human) RN - EC 3.4.21.- (Serine Endopeptidases) SB - IM MH - Activin Receptors, Type II/*genetics/*metabolism MH - Apoptosis/*genetics MH - Carcinoma, Non-Small-Cell Lung/*genetics/*pathology MH - Cell Cycle Proteins/genetics/metabolism MH - Cell Line, Tumor MH - Cell Proliferation/*genetics MH - Gene Expression/genetics MH - Gene Expression Regulation, Neoplastic/*genetics MH - Humans MH - Lung Neoplasms/*genetics/*pathology MH - Microtubule-Associated Proteins/genetics/metabolism MH - RNA, Circular/genetics/metabolism/*physiology MH - Serine Endopeptidases/genetics/metabolism MH - Signal Transduction/*genetics/*physiology PMC - PMC8732839 OTO - NOTNLM OT - Apoptosis OT - Circular RNA OT - EML4-ALK OT - F-circEA1 OT - NSCLC COIS- The authors have no conflicts of interest to declare. EDAT- 2021/10/12 06:00 MHDA- 2022/02/05 06:00 PMCR- 2021/10/11 CRDT- 2021/10/11 12:34 PHST- 2021/05/05 00:00 [received] PHST- 2021/10/01 00:00 [accepted] PHST- 2021/10/12 06:00 [pubmed] PHST- 2022/02/05 06:00 [medline] PHST- 2021/10/11 12:34 [entrez] PHST- 2021/10/11 00:00 [pmc-release] AID - 10.1007/s13577-021-00628-7 [pii] AID - 628 [pii] AID - 10.1007/s13577-021-00628-7 [doi] PST - ppublish SO - Hum Cell. 2022 Jan;35(1):260-270. doi: 10.1007/s13577-021-00628-7. Epub 2021 Oct 11.